Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-070 - BIW-8962, an Anti-GM2 Ganglioside Monoclonal Antibody, in Advanced/Recurrent Lung Cancer: A Phase I/II Study
09:30 - 09:30 | Presenter: Joo-Hang Kim | Author(s): J. Lee, Sang-We Kim, Jin-Hyoung Kang, Dae Ho Lee, Byoung Chul Cho, N. Shiraishi, V. Strout, Keunchil Park
- Abstract
Loading...
-
+
MA 03 - Chemotherapy
- 11:00 - 12:30
- 10/16/2017
- Location: Room 502
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Jin-Hyoung Kang, W. Su
-
+
MA 03.01 - Nab-Paclitaxel ± CC-486 as Second-Line Treatment of Advanced NSCLC: Results from the ABOUND.2L+ Study
11:00 - 11:05 | Presenter: Ramaswamy Govindan | Author(s): D. Morgensztern, Manuel Cobo Dols, S. Ponce Aix, Pieter E. Postmus, Jaafar Bennouna, J.R. Fischer, O.J. Vidal, D.J. Stewart, G. Fasola, J. Weaver, M. Wolfsteiner, T.J. Ong
- Abstract
Loading... -
+
MA 03.02 - Timing of B12/Folate Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy: Final Results of the PEMVITASTART Randomized Trial
11:05 - 11:10 | Presenter: Navneet Singh | Author(s): M. Baldi, J. Kaur, Kuruswamy Thurai Prasad, R. Kapoor, Digambar Behera
- Abstract
Loading... -
+
MA 03.03 - Nedaplatin plus Docetaxel versus Cisplatin plus Docetaxel as First-Line Chemotherapy for Advanced Squamous Cell Carcinoma of the Lung
11:10 - 11:15 | Presenter: Shun Lu | Author(s): Z. Chen, C.P. Hu, R. Xin-Ling, Y. Chen, Yong Song, Z. Qiong, Yun Fan, W. Gang, M. Zhi-Yong, Jian Fang, Y. Qi-Tao, Z. Liu
- Abstract
Loading... -
+
MA 03.04 - Discussant - MA 03.01, MA 03.02, MA 03.03
11:15 - 11:30 | Presenter: Adrian G. Sacher
- Abstract
No abstract available for this presentation
-
+
MA 03.05 - Bevacizumab Combined with Chemotherapy for Patients with Advanced NSCLC and Brain Metastasis. A French Cohort Study
11:30 - 11:35 | Presenter: Jaafar Bennouna | Author(s): L. Falchero, R. Schott, F. Bonnetain, M. Coudert, B. Ben Hadj Yahia, C. Chouaid
- Abstract
Loading... -
+
MA 03.06 - Effect of 2L Ramucirumab after Rapid Time to Progression on 1L Therapy: Subgroup Analysis of REVEL in Advanced NSCLC
11:35 - 11:40 | Presenter: Martin Reck | Author(s): Frances A Shepherd, Maurice Pérol, Frederico Cappuzzo, J. Shih, Keunchil Park, K.B. Winfree, E. Alexandris, P. Lee, A. Sashegyi, Edward Brian Garon
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA 03.08 - Discussant - MA 03.05, MA 03.06, MA 03.07
11:45 - 12:00 | Presenter: Ikuo Sekine
- Abstract
No abstract available for this presentation
-
+
MA 03.09 - The Cost and the Benefit: Front-Line Immunotherapy for Non-Small Cell Lung Cancer
12:00 - 12:05 | Presenter: Christine M Bestvina | Author(s): Everett E Vokes, P.C. Hoffman, J. Patel
- Abstract
Loading... -
+
MA 03.10 - Prognostic Factors in NSCLC Patients Treated with a Fourth-Line Therapy
12:05 - 12:10 | Presenter: Vincent Leroy | Author(s): J. Labreuche, T. Gey, G. Terce, M.C. Willemin, X. Dhalluin, E. Wasielewski, A. Scherpereel, Alexis B Cortot
- Abstract
Loading... -
+
MA 03.11 - Targeting CDCA3 Enhances Sensitivity to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer
12:10 - 12:15 | Presenter: Mark N Adams | Author(s): J. Burgess, D. Richard, Kenneth Obyrne
- Abstract
Loading... -
+
MA 03.12 - Discussant - MA 03.09, MA 03.10, MA 03.11
12:15 - 12:30 | Presenter: Mary Obrien
- Abstract
No abstract available for this presentation
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.03 - Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations
16:05 - 16:15 | Presenter: Keunchil Park | Author(s): K. Azuma, C. Tsai, Takashi Seto, H. Nokihara, James Chih-Hsin Yang, Sang-We Kim, H. Murakami, Makoto Nishio, K. Kiura, A. Inoue, K. Takeda, Jin-Hyoung Kang, Hidetoshi Hayashi, T. Nakagawa, Y. Kaneko, R. Akazawa, M. Shimazaki, S. Morita, M. Fukuoka, Kazuhiko Nakagawa
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-022 - Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Jin-Hyoung Kang | Author(s): S. Hong, H.J. Ahn, K..H. Kim, S.S. Lee, Y.G. Lee, Y.J. Yuh, P. I Cheon, Y.S. Chae, T.W. Jang
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-050 - A Real World Treatment Study of Osimertinib: ASTRIS Study Korean Subgroup Analysis
09:30 - 09:30 | Presenter: Byoung Chul Cho | Author(s): D. Kim, Keunchil Park, J. Lee, S.S. Yoo, Jin-Hyoung Kang, Sung Yong Lee, C.H. Kim, S.H. Jang, Young-Chul Kim, H. Yoon, Sang-We Kim
- Abstract
Loading...
-
+
P3.08 - Locally Advanced Nsclc
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Locally Advanced NSCLC
-
+
P3.08-003 - Multimodal Treatment in the Initially Inoperable Stage III N2 Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Eun Kyo Joung | Author(s): J. Lee, I. Kim, J. Yang, J.K. Park, S. Sung, Jin-Hyoung Kang, S. Hong
- Abstract
Loading...